TrianecT develops and commercializes StrokePointer to diagnose stroke in the ambulance
TrianecT has raised $1.6M in total funding. The most recent round was Seed. The last funding was announced in July 2025.
TrianecT's investors include XO Ventures, CbusineZ.
TrianecT is headquartered in Utrecht, The Netherlands.
TrianecT develops and commercializes StrokePointer to diagnose stroke in the ambulance
TrianecT is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TrianecT — Funding & Investors." VCBacked, July 8, 2025, https://www.vcbacked.co/company/trianect. Accessed July 19, 2026.
VCBacked. (2025). TrianecT — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/trianect
{{cite web |title=TrianecT — Funding & Investors |url=https://www.vcbacked.co/company/trianect |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated